Stock Market Review #shorts 30AUG23

The novel once-daily kappa opioid receptor antagonist navacaprant significantly reduced symptoms of depression and anhedonia in participants with moderate-to-severe major depressive disorder in a phase

As the le­gal land­scape for re­pro­duc­tive rights in the US re­mains in flux, De­moc­rats in the Sen­ate are call­ing on the Biden ad­min­is­tra­tion to re­quire